Translucent
Category: AI in Healthcare
An AI-powered agentic platform that serves as a 24/7 AI Financial Analyst specifically designed for healthcare operators, enabling real-time financial visibility and automated analysis across medical groups and health systems. Translucent was founded in 2024. The company is led by Jack O'Hara. Based in New York City, USA. Team size: 10-50. Total funding raised: $34.0M. Latest round: Series A ($27.0M, March 2026). Key investors include ["GV (Google Ventures)","NEA (New Enterprise Associates)","Virtue","FPV Ventures","Redesign Health"].
- Founded
- 2024
- Headquarters
- New York City, USA
- Team size
- 10-50
- Total funding
- $34.0M
Value proposition
Automates 97% of routine financial analysis without manual effort, increases finance team capacity by 56% without adding headcount, and enables real-time decision-making versus traditional 6-12 month reporting delays. Replaces 40-60 hours of manual spreadsheet work with 2-minute automated reports.
Products and solutions
["AI Financial Analyst with chat-based interface","Claims tracking and analysis (charge to payment by service line, provider, payer)","Labor cost tracking (enterprise totals to individual provider expenses)","Clinical Output monitoring (encounters to wRVUs)","Real-time P&L performance by service line, department, and site","Budget & Forecast tracking with gap identification","Contract Economics monitoring across payers and providers","Specialized service line agents (physician compensation, pharmacy rebates, etc.)"]
Unique value
First agentic AI platform built exclusively for healthcare finance that combines deep domain expertise with fine-tuned AI models. Platform integrates with customer data warehouses in weeks (not months), builds custom data models with organization-specific business logic, and uses a reasoning loop that marries LLM chat-based queries to the right Python/SQL scripts for calculations.
Target customer
Healthcare operators at medical groups and health systems, including VPs of Operations, finance teams, CFOs, and department heads managing service lines with $200M+ revenue
Industries served
["Healthcare Providers","Medical Groups","Health Systems","Hospital Finance","Healthcare Finance & Analytics","Revenue Cycle Management"]
Technology advantage
Enterprise agentic AI architecture integrating specialized models, fine-tuned agent workflows, and evaluations & issue resolution capabilities achieving 95% accuracy on business-specific queries (versus 85% ceiling with standard approaches). Platform creates a data flywheel where each customer interaction enriches the collective knowledge base, with agents becoming more effective across diverse healthcare organizations. Text-to-SQL performance improved from 75% (2023) to 98% on benchmarks through healthcare-specific fine-tuning.
How they differentiate
First AI-native agentic platform built exclusively for healthcare finance operators with chat-based interface for non-technical users, achieving 95% accuracy through healthcare-specific fine-tuning vs. 85% standard approaches. Offers real-time financial visibility vs. traditional 6-12 month reporting delays, with 4-6 week implementation and 97% automation of routine financial analysis. Unlike competitors focused on general RCM or legacy systems with AI added, Translucent is AI-native from inception.
Main competitors
["AKASA","FinThrive","R1 RCM"]
Key partnerships
["GV (Google Ventures) - Series A Lead Investor","NEA (New Enterprise Associates) - Seed & Series A Investor","Virtue - Seed Investor","FPV Ventures - Seed Investor","Redesign Health - Seed Investor","Early customers including Springfield Clinic, Wray Community District Hospital and Clinic"]
Notable customers
["Northwestern Medicine","Duly Health and Care","Wray Community District Hospital and Clinic","Springfield Clinic"]
Major milestones
["Founded in 2024 by former healthcare CIO who witnessed hospital financial crisis","Launched with $7M oversubscribed seed round in August 2025","Achieved preemptive, oversubscribed Series A just 7 months after seed round","Series A led by GV (Google Ventures) in March 2026","Built first agentic AI platform specifically for healthcare finance","Developed 95% accuracy on business-specific queries through fine-tuned AI models","Customer reported 40-60 hours of manual work reduced to 2 minutes"]
Growth metrics
97% automation of routine financial analysis without manual effort, 56% increase in finance team capacity without adding headcount, text-to-SQL performance improved from 75% to 98% through healthcare-specific fine-tuning, reduces 40-60 hours of manual spreadsheet work to 2-minute automated reports
Market positioning
Mid-market enterprise SaaS challenger targeting healthcare operators at medical groups and health systems with $200M+ revenue. Positioned as 'ChatGPT for provider finances' - giving every healthcare operator their own AI Financial Analyst rather than requiring specialized finance or technical expertise.
Geographic focus
United States, with headquarters in New York City and customers across multiple states including Colorado, Illinois, and other regions. Primary focus on U.S. healthcare market.
Patents and IP
No registered patents disclosed as of latest update
About Jack O'Hara
Co-Founder & CEO at Translucent. Former CIO at ChenMed and Springfield Clinic, multi-billion dollar medical groups where he led teams of 300+ across product, engineering, and AI. Previously served as Chief Product and Engineering Officer at Curity and IT Director at Mount Sinai Health System. Rebuilt financial claims systems from the ground up at ChenMed. Recognized as 2024 Enterprise Finalist by South Florida ORBIE Awards for CIO leadership.
Official website: https://www.translucent.co/